Natural killer cells in antitumour adoptive cell immunotherapy

嵌合抗原受体 免疫疗法 NK-92 免疫学 癌症免疫疗法 白细胞介素21 淋巴因子激活杀伤细胞 癌症研究 生物 自然杀伤细胞 免疫系统 T细胞 细胞毒性 体外 生物化学
作者
Tamara J. Laskowski,Alexander Biederstädt,Katayoun Rezvani
出处
期刊:Nature Reviews Cancer [Nature Portfolio]
卷期号:22 (10): 557-575 被引量:850
标识
DOI:10.1038/s41568-022-00491-0
摘要

Natural killer (NK) cells comprise a unique population of innate lymphoid cells endowed with intrinsic abilities to identify and eliminate virally infected cells and tumour cells. Possessing multiple cytotoxicity mechanisms and the ability to modulate the immune response through cytokine production, NK cells play a pivotal role in anticancer immunity. This role was elucidated nearly two decades ago, when NK cells, used as immunotherapeutic agents, showed safety and efficacy in the treatment of patients with advanced-stage leukaemia. In recent years, following the paradigm-shifting successes of chimeric antigen receptor (CAR)-engineered adoptive T cell therapy and the advancement in technologies that can turn cells into powerful antitumour weapons, the interest in NK cells as a candidate for immunotherapy has grown exponentially. Strategies for the development of NK cell-based therapies focus on enhancing NK cell potency and persistence through co-stimulatory signalling, checkpoint inhibition and cytokine armouring, and aim to redirect NK cell specificity to the tumour through expression of CAR or the use of engager molecules. In the clinic, the first generation of NK cell therapies have delivered promising results, showing encouraging efficacy and remarkable safety, thus driving great enthusiasm for continued innovation. In this Review, we describe the various approaches to augment NK cell cytotoxicity and longevity, evaluate challenges and opportunities, and reflect on how lessons learned from the clinic will guide the design of next-generation NK cell products that will address the unique complexities of each cancer. This review gives an overview of natural killer (NK) cell-based immunotherapies. The authors describe the various engineering strategies used to increase NK cell cytotoxicity and persistence, as well as the current challenges and opportunities for the future design of next-generation NK cell therapies.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
chinokuri完成签到,获得积分10
1秒前
科研通AI6.3的应助被整齐成仁采纳,获得10
1秒前
bingbing发布了新的文献求助10
1秒前
Jennifer发布了新的文献求助10
1秒前
1秒前
人间无事人完成签到,获得积分10
1秒前
XIZHENG_完成签到,获得积分10
1秒前
Alane完成签到,获得积分10
1秒前
文章毕业顺利完成签到,获得积分10
1秒前
2秒前
2秒前
cici完成签到,获得积分10
3秒前
铁甲小宝发布了新的文献求助10
3秒前
3秒前
Leungcc发布了新的文献求助10
4秒前
winwin完成签到,获得积分10
4秒前
lyon发布了新的文献求助10
4秒前
嘉禾望岗发布了新的文献求助10
4秒前
4秒前
orixero的应助被wenlong采纳,获得10
4秒前
Hkss1en发布了新的文献求助10
4秒前
5秒前
cc2004bj发布了新的文献求助20
5秒前
will发布了新的文献求助10
5秒前
yanzi发布了新的文献求助10
5秒前
搜集达人的应助被飒奥采纳,获得30
6秒前
Endnote完成签到,获得积分10
6秒前
刘冰芸发布了新的文献求助10
6秒前
dongdongliu完成签到,获得积分10
6秒前
科研通AI65的应助被ONE采纳,获得10
6秒前
huang发布了新的文献求助10
7秒前
YW完成签到,获得积分10
8秒前
8秒前
8秒前
亭亭玉立完成签到,获得积分10
8秒前
8秒前
芭乐发布了新的文献求助10
8秒前
molihuakai的应助被xxx采纳,获得10
9秒前
QiongYin_123完成签到 ,获得积分10
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182352
求助须知:如何正确求助?哪些是违规求助? 9571930
关于积分的说明 21820825
捐赠科研通 7778861
什么是DOI,文献DOI怎么找? 3433657
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479703